{"id":"W2049260196","doi":"10.1016/j.jcf.2014.12.013","title":"A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients","year":2015,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"University of North Carolina at Chapel Hill; Hospital for Sick Children; University of Washington","keywords":"Medicine; Tobramycin; Levofloxacin; Cystic fibrosis; Inhalation; Exacerbation; Clinical endpoint; Dysgeusia; Adverse effect; Internal medicine; Aztreonam; Pseudomonas aeruginosa; Randomized controlled trial; Anesthesia; Antibiotics; Ceftazidime","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002609076,0.002124365,0.004558512,0.0004329438,0.0007346646,0.001480669,0.001227758,0.002723828,0.008462062],"category_scores_gemma":[0.003000638,0.0009537198,0.002702335,0.0004836748,0.00226933,0.002218584,0.0006018477,0.005238894,0.001609517],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001184384,"about_ca_system_score_gemma":0.001750228,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00100288,"about_ca_topic_score_gemma":0.002052907,"domain_scores_codex":[0.9989644,0.0005145344,0.0000627819,0.0002247672,0.00006946971,0.0001640272],"domain_scores_gemma":[0.9978617,0.000715649,0.0004256324,0.000192588,0.0001357665,0.0006686983],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9889746,0.00505315,0.0002224711,0.0001278602,0.0003698499,0.00002095425,0.00002497249,0.0001236441,0.00120993,0.00005203419,0.0002521372,0.003568303],"study_design_scores_gemma":[0.945213,0.05362782,0.0004462583,0.000009331139,0.0001501206,0.0000144455,0.0000117922,0.0001869126,0.0001287487,0.0000696521,0.0001333762,0.000008592847],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874173,0.002780203,0.001038541,0.0009962028,0.0007107495,0.004318493,0.001005172,0.0001445526,0.001588846],"genre_scores_gemma":[0.9840384,0.001549494,0.002750851,0.001980877,0.0006936279,0.005171733,0.001358346,0.00004483789,0.002411853],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008462062,"threshold_uncertainty_score":0.02830845,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05925007916964949,"score_gpt":0.3767043905778113,"score_spread":0.3174543114081618,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}